Literature DB >> 25859443

Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

N A A Amartey1, K Nsiah2, F O Mensah2.   

Abstract

INTRODUCTION: Diabetes mellitus is one of the most common metabolic diseases worldwide. This metabolic disorder contributes greatly to the significant proportion of the burden of renal damage and dysfunction. The aim of the study was to investigate the renal function of the diabetic patients who visit the Clinical Analysis Laboratory (CAn-Lab) at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
MATERIALS AND METHODS: Demographic data as well as medical history were obtained through the administration of a questionnaire. Anthro-pometric measurements were taken and blood samples were analysed for glucose, uric acid, urea and creatinine. Data collected were analysed using SPSS version 16.0.
RESULTS: A total of 34 diabetic patients, aged from 40-77 y were recruited, 22 (64.7%) of them were males with mean age of 57.40 ± 11.8 y (±SD), while 12 (35.3%) were females with mean age of 58.17 ± 7.47 y. There was a statistically significant difference between the mean duration of the disease, as the females had longer duration, 12.50 ± 6.95 y, as compared to 7.32 ± 4.48 y in males (p=0.033). The mean plasma creatinine level in the females was 84.17 ± 54.73 μmol/l. In the diabetic population, there was a positive correlation between age and plasma creatinine level, (r=0.375, p=0.029). In the female diabetics, there was a positive correlation between fasting blood sugar (FBS) and the measured metabolic end products (r>0.5, p<0.05), a positive correlation between body mass index (BMI) and uric acid (r=0.576, p=0.005) and a positive correlation between BMI and FBS (r= 0.625, p= 0.030).
CONCLUSION: Our results on the parameters measured; show that the diabetic population was experiencing mild kidney dysfunction, compared to non-diabetic controls.

Entities:  

Keywords:  Creatinine; Diabetes; Kidney dysfunction; Urea; Uric acid

Year:  2015        PMID: 25859443      PMCID: PMC4378725          DOI: 10.7860/JCDR/2015/10905.5530

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

Review 1.  Uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

Review 2.  Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

Authors:  E Cholongitas; V Shusang; L Marelli; D Nair; M Thomas; D Patch; A Burns; P Sweny; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2007-10-01       Impact factor: 8.171

Review 3.  Oxidative stress, diabetes, and diabetic complications.

Authors:  Wei Wei; Qiuju Liu; Yi Tan; Lucheng Liu; Xiaokun Li; Lu Cai
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

Review 4.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 5.  Chronic kidney disease: the global challenge.

Authors:  A Meguid El Nahas; Aminu K Bello
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

6.  Nutritional regulation of insulin secretion: implications for diabetes.

Authors:  Philip Newsholme; Mauricio Krause
Journal:  Clin Biochem Rev       Date:  2012-05

7.  Diabetes in Ghana: a community based prevalence study in Greater Accra.

Authors:  Albert G B Amoah; Samuel K Owusu; Samuel Adjei
Journal:  Diabetes Res Clin Pract       Date:  2002-06       Impact factor: 5.602

8.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

Review 9.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

10.  A case for new therapy for diabetes, is it leptin?

Authors:  Satya P Kalra
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more
  3 in total

1.  Inflammatory Biomarkers of Cardiometabolic Risk in Obese Egyptian Type 2 Diabetics.

Authors:  Lamiaa A A Barakat; Hassan A Shora; Ibrahim M El-Deen; El-Sayed Abd El-Sameeh El-Sayed
Journal:  Med Sci (Basel)       Date:  2017-11-02

2.  Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats.

Authors:  Muruganantham Koothappan; Roshana Devi Vellai; Iyyam Pillai Subramanian; Sorimuthu Pillai Subramanian
Journal:  Diabetes Metab J       Date:  2018-04-24       Impact factor: 5.376

3.  Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.

Authors:  Amal H Hamza; Widad M Al-Bishri; Laila A Damiati; Hanaa H Ahmed
Journal:  Ren Fail       Date:  2016-10-23       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.